At a glance
ClinicalIndex Comparison RecordN/ACompleted· 91 enrolled
Drug / intervention
SYSTANE® BALANCE eyedrops +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of SYSTANE® BALANCE on Conjunctival Staining (CS) Visual Performance (VP) and Tear Film Kinetics (TFK) in Dry Eye Subjects With Lipid Deficiency
In Brief
A clinical study evaluating SYSTANE® BALANCE eyedrops and Minims® Saline 0.9% eyedrops for Dry Eye Syndrome and Lipid Deficiency. Completed, enrolled 91 participants.
Detailed Summary
The purpose of this study is to evaluate the repeated use of SYSTANE® BALANCE on stabilizing the tear film of dry eye patients with an unstable tear film.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndrome, Lipid Deficiency
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 2012
Enrollment StartDec 2012
Primary CompletionNov 2013
TodayJul 2026
First PostedSep 20, 2012
Enrollment StartDec 1, 2012
Primary CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 13.8 years ago
Interventions
SYSTANE® BALANCE eyedropsother
Minims® Saline 0.9% eyedropsother